• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Molecular Diagnostics for Infectious Disease Testing: Testing volume, cost per test, and market potential

$995.00 – $1,990.00

Clear
SKU: KLI1037841 Categories: Diagnostics Market Research, Infectious Disease, Molecular & Nucleic Acid Testing Pages: 130
  • Description
  • Table of Contents
  • Latest reports

Description

Currently, the largest market application segment for molecular diagnostics is that for infectious disease testing. The segment is expected to grow at an annual rate between 7% and 8% over the next few years will present some excellent market opportunites for molecular diagnostic competitors.

This summary report, extracted from Kalorama Information’s U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of infectious disease testing.

The major market effects of new diagnostics—with the potential of a breakthrough product always a possibility—are being seen and are expected to significantly impact the market over the next ten years. The technology trends selected in conjunction with the growing interest in molecular diagnostics and their application to current health priorities (e.g., HIV/AIDS, cancer, sexually transmitted diseases, etc.) present the most informative picture of advances in this field and the markets that result.

Market analysis considers various infectious disease diagnostic applications of molecular testing rather than the markets for specific technologies in the U.S. This report does not consider instrumentation, such as thermocyclers, luminometers, sequencers, etc. and their disposable support products. Some mention is made of such instrumentation, but greater emphasis is placed on applications and the technologies that will address those specific applications. The focus of the report is on molecular diagnostics technologies and products with the potential to become first-line methods for use in the clinical laboratory for infectious disease testing, and not for research or genomic data collection and cataloguing.

The analysis presented in this report is based on data from a combination of company, government, industry, and institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including molecular biologists, laboratory medicine professionals, pathologists, research scientists, business development managers and marketing managers

Table of Contents

Overview

Scope and Methodology

Market Context

Exhibit 1: Distribution of Molecular Diagnostics Testing in U.S. 2004

Infectious Disease Testing: Targets and Trends

Chlamydia trachomatis

Neisseria gonorrhoeae

Pneumonia

Human Immunodeficiency Virus (HIV)

Tuberculosis

Hepatitis B Virus (HBV)

Hepatitis C Virus (HCV)

Herpes Simplex Virus (HSV)

West Nile Virus (WNV)

Products and Progress of Note

Exhibit 2: Commercially Available Molecular Diagnostic Tests for Infectious Diseases………..

Recent Research Studies: Prospects and Advances in Testing

Number of Tests

Exhibit 3: Projected Infectious Disease Testing by

Molecular Diagnostics in U.S. 2003-2013

Exhibit 4: Trending in Projected Test Volume for

Molecular Diagnostics in Infectious Disease Testing in U.S. 2003-2013

Exhibit 5: Trending in Projected Test Volume Composition for

Molecular Diagnostics in Infectious Disease Testing in U.S. 2003-2013

Market and Cost per Test Projections, 2003-2013

Exhibit 6: Projected Molecular Diagnostics Infectious Disease Testing

Market Potential in U.S. 2003-2013

Exhibit 7: Trending in Projected Market Potential for

Molecular Diagnostics in Infectious Disease Testing in U.S. 2003-2013

Exhibit 8: Trending in Projected Market Potential Composition for

Molecular Diagnostics in Infectious Disease Testing in U.S. 2003-2013

Exhibit 9: Trending in Projected Estimated Cost Per Test (ECPT) for

Molecular Diagnostics in Infectious Disease Testing in U.S. 2003-2013

Major Competitors

Abbott Diagnostics (Division of Abbott Laboratories)

Affymetrix, Inc.

Ambion RNA Diagnostics (Division of Ambion, Inc.)

Celera Genomics/Celera Diagnostics (Division of Applera Corporation)

Cenetron Diagnostics

Cepheid, Inc.

Chiron Corporation

Dharmacon, Inc.

Digene Corporation

Gen-Probe Incorporated

Innogenetics NV

Nanogen, Inc.

Roche Diagnostics Division/

Roche Molecular Systems F. Hoffmann-LaRoche Ltd.

 

    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)
    June 25, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    June 24, 2025
    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025

Related products

  • Placeholder image

    Genetic Testing: Markets and Users in Medical, Forensic, Paternity, and Food Safety Applications

    $2,625.00 – $5,250.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per...Cosmetic Surgery Market: Procedure Volumes and Fees for the Top Five Procedures,...
Scroll to top